W. L. Gore & Associates' medical business (Gore) today announced trial results evaluating the investigational GORE® VIABAHN® ...

Participants included in the trial have been diagnosed with either aortic dissection or aneurysm involving the aortic arch.

Washington, D.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- This month marks a major milestone in cardiovascular medicine: 25 years ...

Q3 2025 Earnings Call Transcript November 4, 2025 InspireMD, Inc. beats earnings expectations. Reported EPS is $0.4262, ...

LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...

Contego Medical announced late-breaking clinical results from the PERFORMANCE III carotid stent study. At 30 days, the 146 patients in the study had no strokes or myocardial infarctions, and there ...

BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

BD (NYSE: BDX) today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study.

Miami-based medical device developer InspireMD has appointed Peter Soukas, MD, as chief medical officer to support the company’s clinical strategy as the firm brings its CGuard Prime carotid stent to ...

InspireMD (Nasdaq:NSPR) announced today that it appointed Dr. Peter A. Soukas as its new chief medical officer.

MIAMI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today ...

InspireMD, Inc. announced the appointment of Peter A. Soukas, MD, as Chief Medical Officer. InspireMD is the developer of the C ...